Southlake Regional Health Centre is a hospital located in Newmarket, Ontario, Canada. Through various expansions during its history, it has grown into a university-affiliated teaching and research facility, specifically offering advanced cardiac, cancer and thoracic care.

There are 500 beds in Southlake Regional Health Centre.

During the past decade, Southlake Regional Health Centre conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 20 clinical trials were completed, i.e. on average, 34.5% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 11 clinical trials were completed. i.e. 68.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southlake Regional Health Centre" #1 sponsor was "Medtronic Cardiac Rhythm and Heart Failure" with 8 trials, followed by "Ottawa Heart Institute Research Corporation" with 8 trials sponsored, "NCIC Clinical Trials Group" with 7 trials sponsored, "Abbott Medical Devices" with 6 trials sponsored and "Biosense Webster, Inc." with 6 trials sponsored. Other sponsors include 73 different institutions and companies that sponsored additional 56 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southlake Regional Health Centre" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 11 trials as a collaborator, "Medtronic" with 7 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator, "National Cancer Institute (NCI)" with 6 trials as a collaborator and "Southlake Regional Health Centre" with 5 trials as a collaborator. Other collaborators include 83 different institutions and companies that were collaborators in the rest 70 trials.

According to Clinical.Site data, the most researched conditions in "Southlake Regional Health Centre" are "Atrial Fibrillation" (29 trials), "Heart Failure" (6 trials), "Persistent Atrial Fibrillation" (6 trials), "Myocardial Infarction" (5 trials) and "Acute Myocardial Infarction" (3 trials). Many other conditions were trialed in "Southlake Regional Health Centre" in a lesser frequency.

Most popular intervention types in "Southlake Regional Health Centre" are "Drug" (42 trials), "Device" (35 trials), "Procedure" (18 trials), "Other" (15 trials) and "Behavioral" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Apixaban" (3 trials), "Rivaroxaban" (3 trials), "gemcitabine hydrochloride" (3 trials) and "Anti-Arrhythmic Drug Therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Southlake Regional Health Centre" are 104 trials for "All" genders, 6 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Southlake Regional Health Centre". undefined are not yet recruiting, 6 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 71 completed trials in Southlake Regional Health Centre, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Southlake Regional Health Centre, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 50 trials that are defined as “Not Applicable".

Southlake Regional Health Centre has several departments that took part in Clinical trials: "Stronach Regional Health Centre at Southlake" - 32 trials